Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHC.L Regulatory News (PHC)

  • There is currently no data for PHC

Director/PDMR Shareholding

31 Jan 2007 07:01

Plant Health Care PLC31 January 2007 31 January 2007 Plant Health Care PLC ("Plant Health Care" or "the Company") Directors' Dealings Directors' Exercise of Options The Company was notified on 30 January 2007 that, on the same day, Dr DonaldMarx, a director of the Company, exercised options over 715,761 ordinary sharesof 1p each in the Company ("Ordinary Shares") at an exercise price of 37 penceper Ordinary Share and options over 34,237 Ordinary Shares at an exercise priceof 71 pence per Ordinary Share. Accordingly, on 30 January 2007 Dr Marxexercised a total of 749,998 options over Ordinary Shares. The Company was notified on 30 January 2007 that, on the same day, Mr JohnBrady, a Director of the Company, exercised options over 300,000 Ordinary Sharesat a price of 37 pence per Ordinary Share. Directors' Dealings The Company was notified on 30 January 2007 that, on the same day Dr Marx and MrBrady sold 900,000 Ordinary Shares and 300,000 Ordinary Shares respectively allat a price of 225 pence per Ordinary Share. All of these 1.2 million OrdinaryShares sold by Dr Marx and Mr Brady were as a result of the exercise of options(described above), with the exception of 150,002 Ordinary Shares held by DrMarx. Directors' Interests and Admission of Ordinary Shares Following the exercise of options and share sales described above, thebeneficial interests of the directors in the Company's Ordinary Share capitalare set out below: Name Ordinary Percentage of Share Options Shareholding issued Ordinary Share capital Dr Albert Fischer 143,371 0.35% 225,000John Brady Nil Nil 1,200,000Walter Bratkowski Nil Nil 200,000Dr Robert Chanson 135,166 0.33% 210,000Thomas Isler 400,846 0.97% 202,500Dr Donald Marx 428,813 1.04% 3,470Samuel Wauchope 52,232 0.13% Nil Application has been made for 1,049,998 Ordinary Shares being issued pursuant tothe exercise of options described above, to be admitted to trading on the LondonStock Exchange's AIM market for listed securities ("Admission"). Admission isexpected to occur on 5 February 2007. The New Shares will rank pari passu withthe Company's existing Ordinary Shares. Following admission of the New Shares, the total issued share capital of the Company will be 41,428,422 Ordinary Shares, all of which have voting rights. The above figure (41,428,422) may be used by shareholders as the denominator forthe calculations by which they will determine if they are required to notifytheir interest in, or a change to their interest in, Plant Health Care plc underthe FSA's Disclosure and Transparency Rules. For further information: Tavistock ComunicationsJeremy Carey/Matt RidsdaleTel: +44 20 7920 3150 Plant Health Care PLCAndrew Wood, Company Secretary Tel: +44 (0) 20 8866 5702 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
27th Jan 20214:41 pmRNSSecond Price Monitoring Extn
27th Jan 20214:36 pmRNSPrice Monitoring Extension
25th Jan 20217:00 amRNSTrading Statement
11th Jan 20217:00 amRNSNotice of Trading Statement/Investor Presentation
5th Jan 20213:37 pmRNSBrazil approves PHC279 to Control Soybean Rust
11th Dec 20207:00 amRNSInvestor Presentation
9th Nov 20207:00 amRNSPlant Health Care and Wilbur-Ellis sign Agreement
7th Oct 20207:00 amRNSGrant of Options
6th Oct 20207:00 amRNSNew US PREtec Patents Issued
2nd Oct 20205:48 pmRNSSignificant Shareholder
25th Sep 20207:00 amRNSInvestor Presentation
23rd Sep 20207:00 amRNSInvestor Presentation
15th Sep 20207:00 amRNSInterim Report 30 June 2020
29th Jul 20207:00 amRNSTrading Statement
26th Jun 20204:41 pmRNSSecond Price Monitoring Extn
26th Jun 20204:36 pmRNSPrice Monitoring Extension
25th Jun 20207:00 amRNSGrant of Options
18th Jun 20204:41 pmRNSSecond Price Monitoring Extn
18th Jun 20204:36 pmRNSPrice Monitoring Extension
16th Jun 20207:00 amRNSPHC398 Approved by US EPA: PHC279 submitted to EPA
9th Jun 20207:00 amRNSGrant of options
2nd Jun 202011:13 amRNSResult of AGM
29th May 20207:00 amRNSHolding(s) in Company
27th May 20207:00 amRNSUpdate on PHC279 2019 Field Trials
6th May 20205:12 pmRNSAnnual Report & Accounts and AGM Notice Published
1st May 20203:21 pmRNSDirector/PDMR Shareholding
24th Apr 20207:00 amRNSResults for the year ended 31 December 2019
25th Mar 20207:00 amRNSHolding(s) in Company
23rd Mar 20203:45 pmRNSHolding(s) in Company
19th Mar 20203:09 pmRNSHolding(s) in Company
16th Mar 202011:53 amRNSResults of General Meeting
11th Mar 20207:00 amRNSPHC279 Submitted for Regulatory Approval in Brazil
24th Feb 20209:18 amRNSResults of Placing and Subscription
24th Feb 20207:00 amRNSProposed Placing and Subscription
19th Feb 20207:00 amRNSBlock listing Interim Review
5th Feb 20207:00 amRNSEmploy California Registration
23rd Jan 20207:00 amRNSFirst US patent issues for PREtec peptide products
9th Jan 20207:00 amRNSBrazil Update
20th Dec 20197:00 amRNSHolding(s) in Company
19th Dec 20197:00 amRNSTrading Update
3rd Dec 20196:35 pmRNSHolding(s) in Company
22nd Nov 20192:11 pmRNSHolding(s) in Company
15th Nov 20193:42 pmRNSHolding(s) in Company
15th Nov 20193:36 pmRNSHolding(s) in Company
14th Nov 20193:36 pmRNSHolding(s) in Company
14th Nov 20197:00 amRNSHolding(s) in Company
13th Nov 20194:40 pmRNSHolding(s) in Company
13th Nov 20194:08 pmRNSHolding(s) in Company
13th Nov 20193:59 pmRNSHolding(s) in Company
13th Nov 20193:42 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.